General
Qulipta (Atogepant)
Virtual visit

Qulipta (Atogepant)

With our quick and easy online prescription process, you can manage your health effortlessly — whether you need a first-time prescription for Qulipta (Atogepant) or a refill of an existing one.

Licensed providers in all 50 states

Expert-guided, evidence-based treatments

Skip the trip to the doctor's office

Visit options

Costs shown are for the visit only. You'll pay for medication at your preferred pharmacy.

Video Visit

$25

Est. or $100 w/o insurance

Chat Visit

$30

w/o insurance

Most insurance accepted

Board-certified

No hidden fees

Available nationwide

What is Qulipta (Atogepant)?

Qulipta is a prescription oral CGRP receptor antagonist taken daily to prevent episodic and chronic migraines in adults. Unlike triptans and other acute migraine treatments that stop an attack once it starts, Qulipta is designed to reduce how often migraines happen in the first place. It works by blocking the CGRP receptor—preventing the calcitonin gene-related peptide from triggering the inflammatory cascade that initiates migraines. Taken once daily as a tablet, it begins reducing migraine frequency within the first month and is one of the most convenient preventive options available, with no injection required.

CGRP receptor blockade

Blocks the receptor for calcitonin gene-related peptide—the neuropeptide central to migraine initiation—preventing CGRP from triggering the trigeminal inflammatory cascade that starts a migraine attack.

Daily oral prevention

Taken as a once-daily pill rather than an injection, Qulipta offers the mechanism-specific migraine prevention of CGRP-targeted biologics in a convenient oral format—lowering the barrier to starting and maintaining preventive therapy.

Episodic and chronic migraine coverage

Approved for both episodic migraine (fewer than 15 headache days per month) and chronic migraine (15 or more), making it one of the few preventive options with evidence and approval across the full spectrum of migraine frequency.

Virtual visit with clinician

Ongoing support, always available.

You’ll be supported by experienced clinicians who care for a wide range of health needs, from everyday concerns to more complex conditions.

Our clinicians track your progress over time and adjust your care as needed. If medication is prescribed, we’ll manage dosing and monitor for side effects. If lab testing is recommended, we review results and refine your plan accordingly. You’re never left to navigate care on your own.

All your care in one place. That’s the General Medicine difference.

We help you understand your options, connect you to the right clinicians, manage prescriptions, coordinate any needed evaluations, and keep an eye on your overall health along the way. It’s comprehensive care that looks at the full picture — your goals, your history, your lifestyle — and makes it simple to move forward with confidence.

Your care plan
Clinician

What our customers have to say

“I feel like I’m finally on the right path to improving my health with the right support now! It’s so refreshing and reassuring.”

Emerald

“My experience with General Medicine was amazing. The understanding and care that was taken to figure out what is exactly going on with me. I feel like a weight has been lifted off of me.”

Kaylee

“I couldn’t be happier with my experience with General Medicine! They are fast, responsive, kind and knowledgeable. It is much easier, more affordable and faster.”

Nika

Get the care you need, without the wait.

Frequently Asked Questions

What is Qulipta and how does it prevent migraines?

Qulipta is an oral CGRP receptor antagonist taken daily to prevent migraines — blocking the protein central to migraine initiation. It reduces how often migraines occur rather than stopping attacks in progress.

How is Qulipta different from injectable CGRP-targeting biologics like Ajovy or Emgality?

Qulipta delivers the same targeted CGRP receptor-blocking mechanism as injectable migraine biologics in a convenient daily oral pill — without injections, refrigeration requirements, or clinic visits for administration.

How long before Qulipta reduces my migraine frequency?

Many people notice a reduction in migraine days within the first month of consistent daily use. Clinical trials showed sustained benefit building over 3–6 months — continued daily use is important for maintaining results.

What side effects might I experience?

Nausea, constipation, and fatigue are the most commonly reported side effects. These are generally mild. Qulipta should be used with caution in patients with severe liver or kidney disease, which affects drug clearance.

Is Qulipta approved for both episodic and chronic migraine?

Yes. Qulipta is FDA-approved for prevention of both episodic migraine (fewer than 15 headache days per month) and chronic migraine (15 or more) — one of the broadest approvals among oral migraine preventives.
Logo

© 2026 Path Healthcare Systems Corp.